Spiramycin

Kathryn Dzintars, Pharm.D., BCPS, Paul G. Auwaerter, M.D.
Spiramycin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Spiramycin: not commercially available in the U.S.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treating primary toxoplasmosis in pregnant women to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. Jack S. Remington Laboratory for Specialty Diagnostics; T: 650-853-4828).

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Spiramycin: not commercially available in the U.S.
    • May be obtained as below (see Adult Dosing)
  • Indicated for treating primary toxoplasmosis in pregnant women to prevent congenital toxoplasmosis (IgM titer needs to be confirmed by Dr. Jack S. Remington Laboratory for Specialty Diagnostics; T: 650-853-4828).

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 18, 2022